Cesare Ferrari

APRIL 27, 2024

In the medical device business, the capacity for innovation is commonly regarded as a key competence and a powerful response mechanism for companies operating in our complex and highly competitive environment. The purpose of this post is to help MedTech professionals to better understand the different types of innovation.

Marketing 52

Marketing Medical Medicine Competition 52

European Pharmaceutical Review

DECEMBER 21, 2022

16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. Org Process Res Dev 2020, 24, 10, 1996–2003. Shores BT, Sieg PE, Nicosia AT, et al. EFPIA White Paper on Circular Economy, June 2020.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

Cesare Ferrari

NOVEMBER 6, 2022

In search of a better solution, they began to use manual instruments and surgical drills or competitive products. This group of customers used the previous generation of Medtronic products, but they were not completely satisfied because that product line was unreliable and not very effective. References. Crossing the Chasm. Rogers, E.

Marketing 52

Marketing Sales Sales pitches Media 52

Pharmaceutical Technology

JULY 23, 2008

” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.” ” Supply and revenue Cancer drugs can plug revenue gaps created by loss of patents in other areas, as Pfizer hopes to do when competition for its cholesterol fighter Lipitor opens up in two years’ time.

Side effects 40

Side effects Marketing Pharmaceutical Sales 40

Healthcare Success

OCTOBER 17, 2024

Yeah, for some folks, and you know, and I think my, you know, my role was, I started at Mayo clinic in public affairs on the media relations team in 2000, and then 2003 became manager of the media relations team, and then 2005 heard about this new thing called podcasting at the time which had been invented a year before. It was scary.

Healthcare 109

Healthcare Healthcare Patients Insurance 109

PM360

SEPTEMBER 28, 2022

Each of these topics would represent sweeping changes on their own, and together, the IRA represents arguably the largest change to prescription drug financing in the United States since the Medicare Modernization Act of 2003, which started the Part D program. Figure 1 provides a high-level timeline of key IRA provisions.

Manufacturing 97

Manufacturing Government Prescription Marketing 97

PM360

APRIL 25, 2023

Although AbbVie’s patent for Humira officially expired in 2016, the legal and regulatory delays paused competition for Humira until 2023. The increase, from ASP plus 6% to ASP plus 8%, will last for five years, and may help increase access to and utilization of biosimilars and promote competition in the marketplace.

Marketing 97

Marketing Competition Government Manufacturing 97

Pharmaceutical Technology

SEPTEMBER 22, 2022

AstraZeneca ’s cholesterol drug Crestor (rosuvastatin) was approved in 2003 in the US but only approved in Germany in 2008. The company now faces a highly competitive generics market for its lead drug. Amarin’s net product revenue was $577.9 million in 2021 and $607 million in 2020, as per its financial filings.

Pharmaceutical 52

Pharmaceutical Marketing FDA Leads 52

Clarivate

OCTOBER 17, 2024

Since the government first created a Part D benefit with the Medicare Modernization Act of 2003 (MMA) , Democrats have agitated for greater governmental input into the cost of prescription drugs for Medicare beneficiaries. As AG, she joined a federal lawsuit to block Anthem and Cigna’s merger in 2016.

Healthcare 52

Healthcare Healthcare Government Insurance 52